Integration of smartphone-based imaging and artificial intelligence (AI)-driven diagnostics provides an effective strategy for screening for rare ocular malignancies, according to a study published online June 4 in JAMA Ophthalmology.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗